Atlas Trials

Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia

Clinical trial NCT06890494 · RECRUITING

Trial details

NCT number
NCT06890494
Sponsor
Beijing GoBroad Hospital
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Leukemia
Start date
2025-01-18
Primary completion
2026-12-31
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.